The big news this week is that the US could finally be on the cusp of rescheduling cannabis. According to reports, the US Department of Health and Human Services (HHS) recommend that Drug Enforcement Administration (DEA) officials place cannabis in Schedule III of the Controlled Substances Act (CSA).
The news follows the publication of a 252 page HHS review, which outlines that cannabis has ‘potential for abuse less than the drugs or other substances in Schedules I and II’.
After a draft bill from the Czech government omitted fully-fledged plans for a commercial adult-use cannabis market, many advocates were up in arms. However, it’s since transpired that this was a deliberate ploy to pressure the bill’s detractors.
Following the success of its recent Medical Cannabis Patients’ Conference, Drug Science UK has outlined details of the event (held in November) – including a thermidor<-produced video – showcasing just how far medical cannabis has come in the past 5 years.
Yet more research throwing down the proverbial gauntlet to those perpetuating the ‘lazy stoner’ stereotype. New studies from the University of Colorado show that runners who consumed cannabis before exercising reported increased mood and enjoyment from exercising.
Despite always being a (perhaps the only) canna-friendly social media platform, LinkedIn has of late seemingly been kicking out cannabis-related content. Could this be a trend? The beginning of the end?
thermidor< is a content-led, cannabis-focused, creative agency. We work with B2B, B2C, and D2C brands to develop messaging, brand, and tone of voice, as well as create written, audio, and visual content such as blogs, whitepapers, podcasts, and event films.
Share this post
sign up for the lobsterpot <
thank you for joining the lobsterpot< newsletter! stay tuned.
Oops! Something went wrong while submitting the form.